Focal Therapeutics Launches BioZorb LP, Expanding Utility of 3D Implant for Breast Cancer Patients
April 07, 2016 15:40 ET
|
Focal Therapeutics
ALISO VIEJO, Calif., April 7, 2016 (GLOBE NEWSWIRE) -- Focal Therapeutics, makers of the three-dimensional BioZorb™ implant used in breast conservation therapy, announced it has launched BioZorb...
Surgeon's Research Is Helping to Improve Breast Cancer Treatment
November 10, 2015 08:22 ET
|
Bellingham Regional Breast Center
BELLINGHAM, WA, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Research presented at a national conference by well-known breast cancer expert Cary Kaufman, M.D. documents pioneering work with a small...
Intermediate-Risk Patients With Organ-Confined Prostate Cancer Have High Cancer-Free Survival Rate After Stereotactic Body Radiation Therapy
October 30, 2012 16:00 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Stereotactic body radiotherapy (SBRT) yields excellent cancer-free survival rates for intermediate-risk, organ-confined prostate cancer patients and results...
High Doses of Stereotactic Body Radiotherapy for Patients With Organ-Confined Prostate Cancer Shows High Relapse-Free Survival
October 30, 2012 15:53 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Patients with organ-confined prostate cancer have new treatment options using high doses of focused stereotactic body radiotherapy (SBRT) instead of...
Annual Prostate Cancer Screening Improves Quality-Adjusted Life Expectancy for High-Risk Patients Compared to Unscreened Patients
October 30, 2012 13:42 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Annual prostate-specific antigen (PSA) screening yields a greater quality-adjusted life expectancy (QALE) among patients who have a high-risk of developing...
Stereotactic Body Radiation Therapy Shows Advances for Inoperable, Non-Small Cell Lung Cancer Patients
October 29, 2012 11:16 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Stereotactic body radiation therapy (SBRT) yielded higher overall survival rates and low toxicity for patients with inoperable, non-small cell lung cancer...
Radiation After Breast-Conserving Surgery Increases Cause-Specific Survival Rate for Older Women With Early-Stage Breast Cancer
October 29, 2012 11:16 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Older women with early-stage, low-risk breast cancer who were treated with radiation therapy (RT) after breast-conserving surgery (BCS) showed higher cause-...
Combination of Surgery and Adjuvant Radiation Treatment Shows Improved Survival for Elderly Women With Early-Stage Breast Cancer
October 29, 2012 11:15 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Elderly women with early-stage breast cancer who received adjuvant radiation therapy after lumpectomy surgery have improved cause-specific survival (CSS)...
25 Years After Breast Cancer Treatment, Patients Who Received Radiation Therapy do Not Have a Higher Risk of Heart Problems
October 29, 2012 11:12 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Breast cancer patients who receive radiation treatment do not have a higher risk of long-term cardiac morbidity when compared to patients undergoing modified...
Sildenafil Citrate Improves Overall Sexual Function of Prostate Cancer Patients Receiving Radiation Therapy
October 29, 2012 11:10 ET
|
American Society for Radiation Oncology
BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Sildenafil citrate (SC), a phosphodiesterase type 5 inhibitor, administered before, during and after radiation therapy improved overall sexual function of...